Versius Paediatrics Study

NCT ID: NCT06539442

Last Updated: 2024-10-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-08

Study Completion Date

2027-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is prospective, multi-phase, single arm, multi-centre, multi-surgeon feasibility clinical trial to provide proof of concept and clinical evidence regarding the safety and efficacy of Versius (robotic surgery medical device) in Urological Procedures in Paediatric population. In alignment with IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework, this study will consist of 3 main phases to ensure proper procedure development while ensuring patients safety. Feasibility and safety will be assessed on an ongoing basis, and specifically after completion of the first 3 procedures, at a single site (Southampton/Lead), each conducted one week apart to allow the identification of unanticipated risks/adverse events. Once deemed safe, based on the results of the 3 cases enrolled in Phase I, 7 further cases would be completed, at the same site. Once the procedure is deemed safe according to safety data collected, the recruitment will proceed to full trial patient accrual, 140 additional cases from the 3 participating study sites.The study patient population is children and adolescents under the age of 18, which will be provided clinical care and follow-ups per standard of care and hospital's policy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Robotic Surgical Procedures in Pediatric Urology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Versius Surgical System

Group Type EXPERIMENTAL

Versius Surgical System

Intervention Type DEVICE

Urological minimal access surgery performed with Versius Surgical System

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Versius Surgical System

Urological minimal access surgery performed with Versius Surgical System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients, male or female, (\<18 years old) for whom an appropriate legal representative provides written consent for participation
* Patient and disease factors deemed suitable for minimal access urological procedure
* Multidisciplinary team (MDT) decision to treat with surgery
* Patients under the care of the paediatric urology team in one of the participating centres

Exclusion Criteria

* Patients ≥ 18 years old
* Appropriate legal representative unwilling to provide written consent
* Medical contraindication for general anaesthesia
* Medical contraindication for laparoscopic procedure
* Active pregnancy (in post-pubertal female patients)
* Morbid obesity (BMI ≥ 40 kg/m2)
* Patient participation in an interventional clinical study, that could impact primary objectives results
* Prior pelvic /abdominal radiotherapy treatment
* Subjects with other clinically significant unstable medical disorder, life-threatening disease, or anything else in the opinion of the Investigator which would contra-indicate a surgical procedure
Minimum Eligible Age

0 Years

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Southampton NHS Foundation Trust

OTHER

Sponsor Role collaborator

CMR Surgical Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ewan Brownlee, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Paediatric Urology Southampton Children's Hospital

David Keene, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Paediatric Urology Royal Manchester Children's Hospital

Pankaj Mishra, MD

Role: PRINCIPAL_INVESTIGATOR

Department of Paediatric Urology, Evelina London Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Paediatric Urology, Evelina London Children's Hospital

London, , United Kingdom

Site Status NOT_YET_RECRUITING

Department of Paediatric Urology Royal Manchester Children's Hospital

Manchester, , United Kingdom

Site Status NOT_YET_RECRUITING

Department of Paediatric Urology Southampton Children's Hospital

Southampton, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mark Slack, MD

Role: CONTACT

+44 7766 024389

Morad Nakhleh, PhD

Role: CONTACT

+44 7518 295217

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pankaj Mishra, MD

Role: primary

David Keene, MD

Role: primary

Ewan Brownlee, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CA-00533

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Multicenter Study of RUS NE
NCT06868186 RECRUITING NA
Prospective Pilot ATOMS vs AUS
NCT05464316 UNKNOWN NA